Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
Docusign's Q4 Beats Estimates
Electronic document management specialist DocuSign (NASDAQ:DOCU) reported fiscal 2025 fourth-quarter financial performance on Thursday, March 13, that topped analysts' consensus expectations. Adjusted EPS of $0.86 slightly surpassed the estimate of $0.85. Fourth-quarter revenue stood at $776.3 milli...
The Motley Fool
Thu, Mar 13
DocuSign Inc reports results for the quarter ended January 31 - Earnings Summary
DocuSign Inc DOCU.OQ reported quarterly adjusted earnings of 86 cents per share for the quarter ended January 31, higher than the same quarter last year, when the company reported EPS of 76 cents. The mean expectation of fifteen analysts for the quarter was for earnings of 85 cents per share. Wal...
Reuters
Thu, Mar 13
EverCommerce Inc reports results for the quarter ended December 31 - Earnings Summary
EverCommerce Inc EVCM.OQ reported quarterly adjusted earnings of 26 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of 12 cents. The mean expectation of nine analysts for the quarter was for earnings of 14 cents per share. W...
Reuters
Thu, Mar 13
TransAct Technologies Inc reports results for the quarter ended December 31 - Earnings Summary
TransAct Technologies Inc TACT.OQ reported a quarterly adjusted loss of 6 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -1 cents. The mean expectation of two analysts for the quarter was for a loss of 9 cents per share. ...
Reuters
Thu, Mar 13
Veritone Inc reports results for the quarter ended December 31 - Earnings Summary
Veritone Inc VERI.OQ reported a quarterly adjusted loss of 20 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -16 cents. The mean expectation of three analysts for the quarter was for a loss of 22 cents per share. Wall Str...
Reuters
Thu, Mar 13
Skillz Inc reports results for the quarter ended December 31 - Earnings Summary
Skillz Inc SKLZ.N reported a quarterly adjusted loss of $1.50 per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of $-1.04. The mean expectation of three analysts for the quarter was for a loss of $1.13 per share. Wall Street expected...
Reuters
Thu, Mar 13
Shimmick Corp reports results for the quarter ended December 31 - Earnings Summary
Shimmick Corp SHIM.OQ reported a quarterly adjusted loss of 91 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -59 cents. The mean expectation of two analysts for the quarter was for a loss of 35 cents per share. Wall Stre...
Reuters
Thu, Mar 13
Regenxbio Inc reports results for the quarter ended December 31 - Earnings Summary
Regenxbio Inc RGNX.OQ reported a quarterly adjusted loss of $1.01 per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-1.43. The mean expectation of ten analysts for the quarter was for a loss of $1.15 per share. Wall Street expec...
Reuters
Thu, Mar 13
Ulta Beauty Inc reports results for the quarter ended January 31 - Earnings Summary
Ulta Beauty Inc ULTA.OQ reported quarterly adjusted earnings of $8.46 per share for the quarter ended January 31, higher than the same quarter last year, when the company reported EPS of $8.08. The mean expectation of twenty seven analysts for the quarter was for earnings of $7.12 per share. Wall...
Reuters
Thu, Mar 13
Joint Corp reports results for the quarter ended December 31 - Earnings Summary
Joint Corp JYNT.OQ reported a quarterly adjusted loss of 18 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -75 cents. The mean expectation of five analysts for the quarter was for earnings of one cent per share. Wall Str...
Reuters
Thu, Mar 13
GrowGeneration Corp reports results for the quarter ended December 31 - Earnings Summary
GrowGeneration Corp GRWG.OQ reported a quarterly adjusted loss of 39 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -44 cents. The mean expectation of five analysts for the quarter was for a loss of 16 cents per share. W...
Reuters
Thu, Mar 13
ServiceTitan Inc reports results for the quarter ended January 31 - Earnings Summary
ServiceTitan Inc TTAN.OQ reported quarterly adjusted earnings of 12 cents per share for the quarter ended January 31. The mean expectation of twelve analysts for the quarter was for earnings of 3 cents per share. Wall Street expected results to range from zero cents to 5 cents per share.Revenue w...
Reuters
Thu, Mar 13
Rubrik Inc reports results for the quarter ended January 31 - Earnings Summary
Rubrik Inc RBRK.N reported a quarterly adjusted loss of 18 cents per share for the quarter ended January 31. The mean expectation of eighteen analysts for the quarter was for a loss of 39 cents per share. Wall Street expected results to range from -41 cents to -37 cents per share.Revenue was $258...
Reuters
Thu, Mar 13
Emeren Group Ltd reports results for the quarter ended December 31 - Earnings Summary
Emeren Group Ltd SOL.N reported a quarterly adjusted loss of 23 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -15 cents. The mean expectation of two analysts for the quarter was for earnings of 8 cents per share. Revenue...
Reuters
Thu, Mar 13
aTyr Pharma Inc reports results for the quarter ended December 31 - Earnings Summary
aTyr Pharma Inc ATYR.OQ reported a quarterly adjusted loss of 18 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -25 cents. The mean expectation of ten analysts for the quarter was for a loss of 23 cents per share. Wall S...
Reuters
Thu, Mar 13
Origin Materials Inc reports results for the quarter ended December 31 - Earnings Summary
Origin Materials Inc ORGN.OQ reported a quarterly adjusted loss of 9 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -7 cents. The lone analyst forecast for the quarter was for a loss of 11 cents per share. Revenue fell 29...
Reuters
Thu, Mar 13
Allogene Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Allogene Therapeutics Inc ALLO.OQ reported a quarterly adjusted loss of 28 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -43 cents. The mean expectation of seventeen analysts for the quarter was for a loss of 33 cents p...
Reuters
Thu, Mar 13
Heartbeam Inc reports results for the quarter ended December 31 - Earnings Summary
Heartbeam Inc BEAT.OQ reported a quarterly adjusted loss of 18 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -15 cents. The lone analyst forecast for the quarter was for a loss of 19 cents per share. Reported revenue was...
Reuters
Thu, Mar 13
How to Identify Undervalued Stocks in a Volatile Market
In this video, we break down how to identify undervalued stocks during periods of market volatility. Just because a stock is trending downward doesn't mean it's a bad investment -- sometimes, the market is simply mispricing a strong business. We discuss key factors to consider, from financial fundam...
The Motley Fool
Thu, Mar 13
Altimmune gains on plans to test weight-loss drug for alcohol use disorder, other conditions
** Shares of drug developer Altimmune ALT.O rose nearly 3% in extended trading before paring gains** Company says that it is planning to test its experimental weight-loss drug, pemvidutide, as a treatment for alcohol use disorder and alcohol-associated liver disease** Plans to begin a mid-stage tria...
Reuters
Thu, Mar 13
1
...
296
297
298
299
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free